🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the Phase 1 research is to test the safety, tolerability, ma...
Status
Recruiting
Location
The Institute for Pulmonary Diseases of Vojvodina
Start Date
2026-03
Trial ID
NCT07391813
Treatments Being Tested
A study of DHP107, a novel oral paclitaxel formulation, to determine maximu...
Status
Completed
Location
Asan Medical Center, University of Ulsan College of Medicine
Start Date
2010-08
Trial ID
NCT02890511
Treatments Being Tested
This is a Phase I open-label, multicenter study designed to evaluate the sa...
Status
Terminated
Location
Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center
Start Date
2019-07-22
Trial ID
NCT04045028
Treatments Being Tested
A first-in-human open-label, Phase I/II study to evaluate the safety, toler...
Status
Recruiting
Location
Jinlin Cancer Hospital
Start Date
2022-07-07
Trial ID
NCT06245330
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as paclitaxel albumin-stabilize...
Status
Completed
Location
University of North Carolina Lineberger Comprehensive Cancer Center
Start Date
2006-08
Trial ID
NCT00307255
Treatments Being Tested
The purpose of this study is to compare the amount of drug that gets into t...
Status
Completed
Location
California Cancer Care Inc
Start Date
2008-08-12
Trial ID
NCT00761722
Treatments Being Tested
Epidermal growth factor receptor（EGFR） is a potential target for new antica...
Status
Completed
Location
Eye & Ear Hospital of Fudan University
Start Date
2011-08
Trial ID
NCT01440270
Treatments Being Tested
Part A: To test the safety and tolerability of combination therapy with Nir...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-10-12
Trial ID
NCT03307785
This is a phase 1/2 study of a drug called Ixazomib in combination with cyt...
Status
Active Not Recruiting
Location
Children's Hospital Los Angeles
Start Date
2019-02-12
Trial ID
NCT03817320
Microlyvaq™ is a first-line, non-randomized, two-arm clinical trial in adva...
Status
Enrolling By Invitation
Location
Biogenea Pharmaceuticals Ltd
Start Date
2026-02-02
Trial ID
NCT07285434
Treatments Being Tested